Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,786 public trials 654 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

NCT03881696

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +5 more
Locations
  • Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology Little Rock, Arkansas, United States
  • Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research Stanford, California, United States
  • National Jewish Health: Division of Pediatric Allergy and Clinical Immunology Denver, Colorado, United States
  • Emory University School of Medicine: Children's Healthcare of Atlanta Pediatrics Atlanta, Georgia, United States
View Trial Details
Completed

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

NCT04400318

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Allianz Research Institute Site Number : 8400020 Westminster, California, United States
  • University of Kansas School of Medicine Site Number : 8400008 Kansas City, Kansas, United States
  • University of Michigan Site Number : 8400002 Ann Arbor, Michigan, United States
  • The Lung Research Center Site Number : 8400010 Chesterfield, Missouri, United States
View all 65 locations
View Trial Details
Completed

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

NCT05186805

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Thousand Oaks, California, United States
  • Dermavant Investigative Site Centennial, Colorado, United States
  • Dermavant Investigative Site Coral Gables, Florida, United States
  • Dermavant Investigative Site Hialeah, Florida, United States
View Trial Details
Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

NCT05014568

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Phoenix, Arizona, United States
  • Dermavant Investigative Site Bryant, Arkansas, United States
  • Dermavant Investigative Site Beverly Hills, California, United States
View all 67 locations
View Trial Details
Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

NCT05032859

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Fort Smith, Arkansas, United States
View all 62 locations
View Trial Details
Completed

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

NCT04130191

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Klinikum der Johann-Wolfgang Goethe-Universitat Frankfurt am Main, Hesse, Germany
  • Charité - Universitätsmedizin Berlin Berlin, Germany
  • Universitatsklinikum Dusseldorf Düsseldorf, Germany
View all 19 locations
View Trial Details

Related conditions